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A new mononuclear Pt(II) complex, [Pt(DMP)(DIP)]Cl2.H2O, in which DMP is 4,4-dimethyl-2,2-bipyridine and DIP is 4,7-di-
phenyl-1,10-phenantroline, has been synthesized and characterized by physicochemical and spectroscopic methods. The binding
interaction of this complex with calf thymus DNA (CT-DNA) was investigated using ﬂuorimetry, spectrophotometry, circular di-
chroism, viscosimetry and cyclic voltametry (CV). UV-VIS spectrum showed 4nm bathochromic shift of the absorption band at
280nm along with signiﬁcant hypochromicity for the absorption band of the complex. The intrnisic binding constant (Kb = 2 ×
104 M
−1) is more in keeping with intercalators and suggests this binding mode. The viscosity measurements showed that the com-
plex-DNAinteractioncanbehydrophobicandconﬁrmintercalation.Moreover,thecomplexinduceddetectablechangesintheCD
spectrum of CT-DNA. The ﬂuorescence studies revealed that the probable quenching mechanism of ﬂuorescence of the complex
by CT-DNA is static quenching. The thermodynamic parameters (ΔH>0a n dΔS>0) showed that main interaction with hydro-
genic forces occurred that is intercalation mode. Also, CV results conﬁrm this mode because, with increasing the CT-DNA con-
centration, shift to higher potential was observed.
1.Introduction
During the recent years, only some platinum compounds
such as cisplatin, carboplatin, and more recently nedaplatin
and oxaliplatin have been known as antitumor compounds
in clinical treatments; the research in this ﬁeld is still increas-
ing [1–5]. The original studies of metallointercalators cen-
tered on square planar platinum(II) complexes containing
phenanthroline ligand [6, 7]. Octahedral transition metal
complexes containing three bipyridine or phenanthroline
ligands have been shown to be groove binders or possible
partial intercalators [8, 9]. Concerning the noncovalent
interactions between transition metal complexes and DNA,
they can occur by intercalation, groove binding, or external
electrostatic binding [10]. In general, metal complexes upon
binding to DNA are stabilized through a series of weak inter-
a c t i o n ss u c ha st h eπ-stacking interactions of aromatic hete-
rocyclic groups between the base pairs (intercalation),
hydrogen bonding, and van der Waals interactions of
functional groups bound along the groove of the DNA helix
[11]. Platinum compounds are an important part of the
ﬁrst line of treatment for many types of cancers such as tes-
ticular and ovarian cancer. Cisplatin, cis-[PtCl2(NH3)2], and
carboplatin, Pt(cbca)(NH3)2 with cbca = 1,1-cyclobutane-
dicarboxylate, has been in use clinically for more than 30
years. Recently, oxaliplatin, Pt(dach)(ox) where dach = R,R-
1,2-diaminocycloexane and ox = oxalate, a third generation
of Pt complexes have been approved for clinical use [12].
McFadyen et al. [13] synthesized a range of Pt(II) complexes
containing substituted phenanthroline ligands and showed
that the complex [Pt(en)(3,4,7,8-Me4phen)]Cl2 was two
or three times more active than the corresponding
phen-based complex [Pt(en)(phen)]Cl2, against murine leu-
kemia cell lines. In this context, we report the results of an
investigation of the interaction with calf thymus DNA of the
complex [Pt(DMP)(DIP)]Cl2·H2O. The data were further
compared with previous results [14] to determine the eﬀect
of metal on the DNA binding mode. Many techniques have2 Bioinorganic Chemistry and Applications
been applied for investigation of the interaction of metal
complexes with DNA. These include (i) molecular spec-
troscopy methods such as UV spectrophotometry [15], ﬂuo-
rescence [16], circular dichroism spectroscopy [17, 18],
dynamic viscosity measurements [19, 20], and high-per-
formance liquid chromatography [21]. Between these tech-
niques, UV spectrophotometry, ﬂuorescence method, dyna-
mic viscosity measurements circular dichroism, and cyclic
voltametry studies have been preferred because small mole-
cule-DNA interaction may be experimentally monitored by
changes in the intensity and position of the spectroscopic
peak responses or changes in dynamic viscosity of DNA.
2. Experimental
All chemicals such as K2PtCl4, 4,7-dimethyl-1,10-phenan-
throline, and 4,4-dimethyl-2,2-bypyridine, were purchased
from Merck, and Tris-HCl and highly polymerized calf thy-
mus DNA (CT-DNA) were purchased from Sigma Co.. Ex-
periments were carried out in Tris-HCl buﬀer at pH 7.0. A
solution of calf thymus DNA gave a ratio of UV absorbance
at 260 and 280nm more than 1.8, indicating that DNA was
suﬃciently free from protein [22]. The stock solution of CT-
DNA was prepared by dissolving DNA in 10mM of the Tris-
HCl buﬀer at pH 7.0. The DNA concentration (monomer
units) of the stock solution (1 × 10−2 Mp e rn u c l e o t i d e )w a s
determined by UV spectrophotometer, in properly diluted
samples, using the molar absorption coeﬃcient
6600M−1 cm−1 at 258nm [23]. The stock solutions were
stored at 4◦C and used over no more than 4 days.
2.1. Synthesis of the [Pt(DMP)(DIP)]Cl2·H2OC o m p l e x .
[Pt(DMP)(DIP)]Cl2·H2O (Figure 1) was synthesized by two
steps. In the ﬁrst step the platinum precursor, K2PtCl4, the
(0.05g, 0.12mmol) was dissolved in 6mL of water and a
solution of 4,4-dimethyl-2,2-bipyridine (0.022, 0.12mmol)
was added dropwise. The mixture was stirred overnight at
50◦C. A yellow precipitate was formed, which was ﬁltered oﬀ
and washed with ice-cold water and acetone. Subsequently
in second step the prepared precipitate in ﬁrst step (0.03g,
0.1mmol) was dissolved in 4mL methanol and a solution
of 4,7-diphenyl-1,10-phenantroline (0.027g, 0.1mmol) in
4mL methanol was added dropwise. The last solution was
reﬂuxed in 180◦C for 4h. A green precipitate was formed,
which was ﬁltered oﬀ and washed with ice-cold water and
diethylether. Yield: 36%. Elemental analysis for PtC36H28N4
Cl2H2O: found: C, 53.2; H, 4.1; N, 6.9%; calc.: C, 54.1; H,
3.6;N,7.0%;FT-IR(KBr,cm−1):3050–3236[ν(C–H)],1230
[ν (C–N)], 1560 [ν (C=N)], 532 [ν (Pt–N)], 3400–3500 [ν
(H2O)].
2.2. Instrumentation. 1H NMR spectra were recorded with
using a Bruker Avance DPX200 MHz (4.7T) spectrometer
using d6-DMSO as solvent. The elemental analysis was per-
formed using Heraeus CHN elemental analyzer. Absorbance
spectra were recorded using a hp spectrophotometer (agilent
8453) equipped with a thermostated bath (Huberpolysat
cc1). Absorption titration experiments were carried out by
CH3 CH3
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Figure 1: The structure of [Pt(DMP)(DIP)]Cl2·H2O complex.
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Figure 2: Absorption spectra of DNA (5 × 10−5 M) in the absence
and in the presence of increasing amounts of platinum complex (ri
= [DNA]/[complex]).
keeping the concentration of DNA constant (5 × 10−5 M)
whilevaryingthecomplexconcentrationfrom5 ×10−5 Mt o
4 × 10−4 M( r i= [DNA]/[complex] = 0–4).
Absorbance values were recorded after each successive
addition of DNA solution and equilibration (ca. 10min)
(Figure 2). The data were then ﬁtted to (1) to obtain intrinsic
binding constant, Kb [24]:
[DNA] 
εa − εf
 =
[DNA] 
εb −εf
 +
1
Kb

εb −εf
,( 1 )
where εa, εf,a n dεb are the apparent, free and bound com-
plex extinction coeﬃcients, respectively. In particular, εf was
determined by a calibration curve of the isolated metal com-
plex in aqueous solution; following the Beer’s law, εa was
determined as the ratio between the measured absorbance
and the Pt(II) complex concentration, Aobs/[Pt]. A plot ofBioinorganic Chemistry and Applications 3
[DNA]/(εa−εf) versus [DNA] gave a slope of 1/(εb−εf)a n d
a Y intercept equal to 1/Kb(εb − εf); Kb is the ratio of the
slope to the Y intercept. CD measurements were recorded
on a JASCO (J-810) spectropolarimeter, keeping the concen-
tration of DNA constant (5 × 10−5 M) while varying the
complex concentration (ri = [complex]/[DNA] = ri = 0, 0.4,
0.5).
Viscosity measurements were made using a viscosimeter
(SCHOT AVS 450) maintained at 25.0 ± 0.5◦C using a cons-
tant temperature bath. The DNA concentration was ﬁxed at
5 × 10−5 M, and ﬂow time was measured with a digital stop-
watch. The mean values of three measurements were used to
evaluate the viscosity η of the samples. The values for relative
speciﬁc viscosity (η/η0)1/3,w h e r eη0 and η are the speciﬁc
viscosity contributions of DNA in the absence (η0) and in
the presence of the complex (η), were plotted against ri (ri =
[complex]/[DNA] = 0.0–2.5).
All ﬂuorescence measurements were carried out with a
JASCO spectroﬂuorometer (FP6200) by keeping the concen-
tration of complex constant while varying the DNA concen-
tration from 0 to 36 × 10−5 M( r i= [DNA]/[complex] = 0.0,
0.5, 1.0, 1.5, 3, 3.5) at three diﬀerent temperatures (288, 298,
308K).
The cyclic voltammetric measurements were performed
using an AUTOLAB model (PG STAT C), with a three-elec-
trode system: a 0.10cm diameter glassy carbon (GC) disc as
working electrode, an Ag/AgCl electrode as reference elec-
trode,andaPtwireascounterelectrode.Electrochemicalex-
periments were carried out in a 25-mL voltammetric cell at
room temperature. All potentials are referred to the Ag/AgCl
reference. Their surfaces were freshly polished with 0.05mm
alumina prior to each experiment and were rinsed using
double-distilled water between each polishing step. The sup-
porting electrolyte was 0.01M of Tris-HCl buﬀer solution
(pH 7.4) which was prepared with double-distilled water.
Before experiments, the solution was deaerated via purging
with pure nitrogen gas for 1min, and, during measurements
a stream of nitrogen was passed over the solution. The cur-
rent-potential curves and experimental data were record-
ed on software GPES [25].
3. Results andDiscussion
3.1. Synthesis and Characterization of [Pt(DMP)(DIP)] Cl2 ·
H2OC o m p l e x .The mixed ligand platinum(II) complex of
4,4-dimethyl-2,2-bipyridine (DMP) and 4,7-diphenyl-1,10-
phenantroline (DIP) has been synthesized in aqueous meth-
anol solution using K2PtCl4. The complex conforms to the
formula [Pt(DMP)(DIP)]Cl2·H2O, determined on the basis
of elemental analysis.
The IR spectrum of the complex was characterized by
the appearance of a band at 532cm−1 due to the [ν (Pt–N)].
Thecoordinationofthenitrogenatomsisconﬁrmedwiththe
presence of this band. However, the broad band at 3400–
3500cm−1 is assigned to [ν(H2O)]. Other bands are at 3050–
3236 [ν (C–H)], 1230 [ν (C–N)], and 1560 [ν (C=N)], res-
pectively.
1H NMR (d6-DMSO). In the aromatic region the signals at
δ = 8.3, δ = 8.1 and δ = 7.1ppm were assigned to protons of
DMP ligands and the signals at δ = 8.9, δ = 7.6, δ = 7.5, and
δ = 7.3 were assigned to the protons of DIP ligand. The pro-
tons of DMP and DIP ligands are seen to be shifted
(≈− 0.2ppm)withcorrespondingfreeligandandsuggesting
complexation.
3.2. UV-VIS Spectroscopy. Absorption spectroscopy is one of
the most useful techniques to study the binding of any drug
to DNA. The extent of hypochromism generally indicates the
intercalative binding strength [26]. The hypochromicity
characteristic of intercalation has usually been attributed to
the interaction between the electronic states of the com-
pound and those of the DNA bases [27], while the red shift
has been associated with the decrease in the energy gap bet-
ween the HOMO and LUMO molecular orbitals after bind-
ing of the complex to DNA [28]. Hyperchromism has been
observed for the interaction of many drugs with DNA [29].
The hyperchromic eﬀect might be ascribed to external con-
tact (electrostatic binding [30]) or to partial uncoiling of the
helix structure of DNA, exposing more bases of the DNA
[31]. We have observed 4nm bathochromic shift of the
absorption band at 280nm along with signiﬁcant hypo-
chromicity for the absorption band of the complex. This ob-
servation gives a good evidence of the intercalation of
Pt(II) complex through the stacking and interaction of the
aromatic rings of the ligands and the base pairs of DNA [32].
Additionally, based on the absorbance values obtained in the
spectroscopic titration, the [Pt(DMP)(DIP)]Cl2·H2Oc o m -
plex-DNA binding constant, Kb, was calculated as described
in the experimental procedure. The value obtained for Kb
was 2.0 ± 0.2 × 104 M−1.T h ev a l u e so fKb described in the
literature for classical intercalators (ethidium-DNA 7 ×
107 M−1 [33] and proﬂavin-DNA 4.1 × 105 M−1 [34]) are at
least 30 or 20 orders of magnitude higher than that obtained
for this Pt(II) complex. This result suggests that intercalation
between the base pairs is not the main mode of interaction
of the Pt(II) complex with DNA. In contrast, the value of Kb
is ten orders of magnitude higher than the Kb values which
were found for compounds with the mode of groove binding
like Cr(II) complexes [35] or tris (1,10-phen) ruthenium(II)
to DNA [36]. These results conﬁrm that the Pt(II) complex
strongly interact with DNA, and the Kb value obtained for
this complex is of the same order of magnitude of that
determined in analogues condition for ZnL+2 (Kb = 7.36 ±
0.01×104 M−1)whichconsideredasanintercalatingcomplex
[37].
3.2.1. Circular Dichroism Spectroscopy. To establish in more
detail whether binding of the complex brings about any sig-
niﬁcantconformationalchangeoftheDNAdoublehelix,cir-
cular dichroism (CD) spectra of CT-DNA were recorded at
increasing complex/CT-DNA ratios. The observed CD spec-
trum of natural calf thymus DNA consists of a positive band
at275nmduetobasestackingandanegativebandat245nm
due to helicity, which is characteristic of DNA in right-hand-
ed B form (Figure 3)[ 38]. The eﬀect of the complex on4 Bioinorganic Chemistry and Applications
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Figure 3: Circular dichroism spectra of CT-DNA (5 × 10−5 M) in
the presence of increasing amounts of Pt(II) complex at the follow-
ing stoichiometric ratios (ri = [complex]/[DNA] = 0.0, 0.4, 0.5).
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Figure 4:EﬀectofincreasingamountsofPt(II)complex onthevis-
cosity of CT-DNA (5 × 10−5 M) in 10mM Tris-HCl buﬀer.
the conformation of the secondary structure of DNA was
studied by keeping the concentration of CT-DNA at 5 ×
10−5 M while varying the concentration of complex in a
buﬀer solution of 10mM of Tris (ri = 0, 0.4, 0.5). The
spectrum of the CT-DNA and those with the additives were
monitoredfrom215to800nm.AsshowninFigure3,theCD
spectrum of DNA exhibits a positive absorption at 282nm
due to the base stacking and a negative band at 240nm due
to the helicity of B-DNA. In the presence of the platinum(II)
complex, the intensity of the positive peak increased and the
intensity of the negative peak decreased. The changes in the
CD spectra in the presence of the complex show stabilization
of the right-handed B form of CT-DNA (Figure 3).
3.2.2. Viscosity Measurements. The viscosity measurements
ofCT-DNAareregardedastheleastambiguousandthemost
critical tests of a binding model in solution in the absence of
crystallographic structural data. The values of relative speci-
ﬁc viscosity (η/η0)1/3 (where η0 and η are the speciﬁc visco-
sity contributions of DNA in the absence and in the presence
of the Pt complex, resp.) were plotted against 1/R (R =
[DNA]/[complex]) (Figure 4). It is known that the groove
binder like Hoechst 33258 does not cause an increase in the
axial length of the DNA [39, 40] and, therefore, did not alter
the relative viscosity. In contrast, cisplatin which is known
to link DNA through covalent binding, shortening the axial
length of the double helix [41], caused a decrease in the
relative viscosity of the solution. Partial intercalators also re-
ducetheaxiallengthobservedasareductioninrelativevisco-
sity, whereas the classical organic intercalators such as ethi-
dium bromide increased the axial length of the DNA, and it
becomes more rigid [39, 40] resulting in an increase in the
relative viscosity. Results conﬁrm the sensitivity of viscosity
measurementstothediﬀerentmodesofDNAbinding.Inthis
study, it was observed that increasing the platinum complex
concentration leaded to an increase of the DNA viscosity.
Thus, we may deduce that the [Pt(DMP)(DIP)]Cl2·H2O
complexcertainlyisaDNAintercalator.Sincetheinteraction
ofthisplatinum(II)complexwithDNAcanmakeDNAlong-
er, we would expect that the relative viscosity of DNA in-
creaseswithaslopebetween0and0.94(avaluemeasuredfor
ethidium bromide [42] if the intercalation of the Pt(II) com-
plex was either only one interaction mode or much
stronger than other interaction(s) (Figure 6). But, in this
study, the relative viscosity of DNA increases with a slope
of 0.38 (Figure 4) and it is reasonably believed that may be
other interaction(s) between DNA and the Pt(II) complex
occurred, and is reasonable for the decrease of the slope.
In addition, it should be noted that the DNA binding
constant measured for this Pt(II) complex is lower than
those determined for ethidium bromide. Therefore, the
greater increase in viscosity observed for ethidium bromide
compared to the Pt(II) complex is likely due to the lower
binding constant of the latter to DNA. These results clearly
show the importance of using several techniques to ascertain
intercalation.
3.2.3. Fluorescence Studies. To further investigate the interac-
tion mode between the complex and CT-DNA, ﬂuorescence
titration experiments was performed. The complex emits
luminescenceinTris-HClbuﬀerwithmaximumwavelengths
of about 386nm. Figure 5 shows the emission spectra of the
complex in the absence and presence of varying amounts
of CT-DNA. In the emission spectra for the complex, with
increasing CT-DNA concentration the emission intensity is
decreased due to self-stacking of some free bases in the com-
pound along the DNA surface [43]. Quenching can occur by
diﬀerent mechanisms, which are usually classiﬁed as dyna-
mic and static quenching. Dynamic quenching refers toBioinorganic Chemistry and Applications 5
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a process in which the ﬂuorophore and the quencher come
into contact during the transient existence of the exited state,
while static quenching refers to ﬂuorophore-quencher com-
plex formation. In general, dynamic and static quenching
can be distinguished by their diﬀering dependence on tem-
perature and excited state lifetime. Since in both cases the
ﬂuorescence intensity is related to the concentration of the
quencher, the quenched ﬂuorophore can serve as an indica-
tor for the quenching agent [44].
FluorescencequenchingisdescribedbytheStern-Volmer
equation:
F0
F
= 1+Kqτ0[Q] = 1+KSV[Q],( 2 )
where F0 and F represent the ﬂuorescence intensities in the
absence and in the presence of quencher, respectively. Kq is
the ﬂuorophore quenching rate constant, KSV is quenching
constant, τ0 is the lifetime of the ﬂuorophore in the absence
of a quencher (τ0 = 10−8), and [Q] is the concentration of
Table 1: The quenching constants of the Pt(II) complex by CT-
DNA at diﬀerent temperatures.
T (K) R2 KSV (Lmol−1) × 105 Kq (Lmol−1) × 1013
288 0.9946 3.53 3.53
298 0.9981 5.42 5.42
308 0.9965 10.34 10.34
Table 2: Binding constants (Kf) and number of binding sites (n)o f
the complex-DNA system.
T (K) n Log Kf Kf R2
288 0.919 5.06 1.14 × 105 0.9979
298 0.958 5.48 3.04 × 105 0.9993
308 0.931 5.60 3.96 × 105 0.9991
quencher [45]. The results in Table 1 indicate that the pro-
bable quenching mechanism of this complex by CT-DNA
involves static quenching, because KSV decreases with in-
creasing temperature [46].
3.3. Binding Constant and the Number of Binding Sites. If it
is assumed that there are similar and independent binding
sites in the biomolecule, the binding constant (Kf) and the
number of binding sites (n) can be determined according to
the method described by Hu et al. [47], using the following
equation:
Log

F0 −F
F

= LogKf +nLog[Q]. (3)
Here, F0 and F are the ﬂuorescence intensities of the ﬂuo-
rophore in the absence and presence of diﬀerent concentra-
tions of CT-DNA, respectively. The values of Kf and n were
found to be 1.14 × 105 M−1 and 1, respectively, (Table 2).
3.3.1. Binding Mode between the Complex and DNA. Accord-
ing to the thermodynamic data, interpreted as follows, the
model of interaction between a drug and biomolecule can be
[48]( 1 )ΔH<0a n dΔS<0, hydrophobic forces; (2) ΔH>0
and ΔS>0, van der Waals interactions and hydrogen bonds;
(3) ΔH>0a n dΔS<0, electrostatic interactions [49]. In
order to elucidate the interaction of our complex with DNA,
the thermodynamic parameters were calculated. The plot of
lnK versus 1/T (Figure 4;( 4)) allows the determination of
ΔH andΔS.Ifthetemperaturedoesnotvarysigniﬁcantly,the
enthalpy change can be regarded as a constant. Based on the
binding constants at diﬀerent temperatures, the free energy
change can be estimated (Table 3;( 5)) by the following equa-
tions
LnK =−
ΔH
RT
+
ΔS
RT
, (4)
ΔG = ΔH − TΔS =− RTLnK, (5)
where K is the Stern-Volmer quenching constant at the cor-
responding temperatures and R is the gas constant. When we
apply this analysis to the binding of the complex with CT-
DNA, we ﬁnd that ΔH>0a n dΔS>0. Therefore, van6 Bioinorganic Chemistry and Applications
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Figure 7: Cyclic voltametry for the Pt (II) complex (10−3 mol/L) at
the presence of diﬀerent concentrations of DNA.
Table 3: Thermodynamic parameters for the binding of the Pt(II)
complex to CT-DNA.
T (K) ΔG
(KJmol−1)
ΔH
(KJmol−1)
ΔS
(Jmol−1 K−1)
288 −28.15 46.03 257.55
298 −30.73 46.03 257.55
308 −33.30 46.03 257.55
der Waals interactions are probably the main forces in the
binding of the investigated complex to CT-DNA.
3.4. Electrochemical Behaviour of the Complex in the Absence
andPresenceofCT-DNA. Recently,theelectrochemicaltech-
niquesextensivelywereusedasasimpleandrapidmethodto
study DNA interaction with diﬀerent compounds. The elec-
trochemical behaviour of platinum is well known and was
strongly inﬂuenced by the electrode material. A well-deﬁned
and sensitive peak was observed from the solutions of the
complex with a GC electrode rather than the Pt one. There-
fore, a GC electrode was used in this investigation. When
CT-DNA is added to a solution of the complex, both the
anodic and cathodic peak current heights of the complex
decreased in the same manner of increasing additions of
DNA,(Figure7).AlsoduringDNAaddition,theanodicpeak
potential (Epa), cathodic peak potential (Epc), and E1/2
(calculatedastheaverageofEpcandEpa)allshowedpositive
shifts. These positive shifts are considered as evidences for
intercalation of the complex into the DNA, because this
kind of interaction is due to hydrophobic interaction. From
the other point of view, if a molecule binds electrostatically
to the negatively charged deoxyribose-phosphate backbone
of DNA, negative peak potential shifts should be detected.
Therefore, the positive shift in the CV peak potentials of
complex is indicative of intercalative binding mode of the
complex with DNA [25].
4. Conclusion
In this paper, we investigate synthesis and characterization of
new platinum(II) complex, and binding with CT-DNA was
studied. The results suggest that the complex binds to DNA
via intercalation mode. Spectrophotometry showed 4nm
bathochromic shift of the absorption band at 280nm along
with signiﬁcant hypochromicity for the absorption band of
the complex. The intristic binding constant (Kb = 2 ×
104 M−1) is more in keeping with intercalators and suggest
this binding mode. The viscosity measurement showed that
the complex-DNA interaction can be hydrophobic and con-
ﬁrmintercalation.Moreover,thecomplexinduceddetectable
changes in the CD spectrum of CT-DNA. The ﬂuorescence
studies revealed that the probable quenching mechanism of
ﬂuorescence of the complex by CT-DNA is static quenching.
The thermodynamic parameters (ΔH>0a n dΔS>0)
showedthatvanderWaalsinteractionsoccurredthatisinter-
calation mode. Also, CV results conﬁrm this mode because,
with increasing CT-DNA concentration, shift to higher
potential was observed.
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